Advertisement
UK markets closed
  • FTSE 100

    8,420.26
    -18.39 (-0.22%)
     
  • FTSE 250

    20,749.90
    -72.94 (-0.35%)
     
  • AIM

    794.02
    +1.52 (+0.19%)
     
  • GBP/EUR

    1.1678
    +0.0023 (+0.20%)
     
  • GBP/USD

    1.2706
    +0.0035 (+0.28%)
     
  • Bitcoin GBP

    52,634.06
    +41.15 (+0.08%)
     
  • CMC Crypto 200

    1,370.71
    -3.14 (-0.23%)
     
  • S&P 500

    5,303.27
    +6.17 (+0.12%)
     
  • DOW

    40,003.59
    +134.21 (+0.34%)
     
  • CRUDE OIL

    80.00
    +0.77 (+0.97%)
     
  • GOLD FUTURES

    2,419.80
    +34.30 (+1.44%)
     
  • NIKKEI 225

    38,787.38
    -132.88 (-0.34%)
     
  • HANG SENG

    19,553.61
    +177.08 (+0.91%)
     
  • DAX

    18,704.42
    -34.39 (-0.18%)
     
  • CAC 40

    8,167.50
    -20.99 (-0.26%)
     

Plasma Fractionation Market Research Report 2023

Company Logo
Company Logo

Dublin, April 28, 2023 (GLOBE NEWSWIRE) -- The "Plasma Fractionation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Albumin, Immunoglobulins, Coagulation Factors, Protease Inhibitors, and Others), By Method, By Application, By End User, By Region, and Competition" report has been added to ResearchAndMarkets.com's offering.

The Global Plasma Fractionation Market is anticipated to witness impressive growth to 2028

This can be ascribed to the growing prevalence of chronic diseases among all age groups, such as immunological disorders and grave diseases, along with increasing demand for immunoglobulins for the treatment of chronic diseases.

Additionally, the growing prevalence of blood and respiratory disorders due to and growing advancement in technology to cure diseases has significantly increased the demand for plasma fractionation across different parts of the globe. Additionally, the growing geriatric population across the globe, which is susceptible to different kinds of chronic diseases, is further expected to increase the demand for plasma fractionation, thereby fuelling market growth through 2028.

ADVERTISEMENT

Besides, growing awareness about the advantages of using plasma fractions for the diagnosis of chronic diseases across the globe is further expected to support the plasma fractionation market during the forecast period.

Furthermore, increasing research and development activities related to immunoglobulin are further expected to increase the demand for dental contouring. According to Statista, as of 2022, around 51 percent of patients with Bernard Soulier syndrome were female, while 49 percent were male.

Growing Prevalence of Immunodeficiency disorder

The increasing incidence of blood and immune disorders and off-label usage of critical plasma products like albumins and immunoglobulins is the main factors that will boost the market growth during the forecast period.

Similarly, the rising use of immunoglobulins and alpha-1-antitrypsin in the medical sector as a plasma fraction will propel the growth of the market. Similarly, increasing demand for plasma-related therapies is important for the treatment of new diseases.

In the present years, usage of protease inhibitors like alpha-1-antitrypsin protein is increased for the treatment of lung diseases and hepatic diseases; this, in turn, is expected to create lucrative growth for the market in the forecast period. For instance, according to the March 2021 report of the Alzheimer's Association, approximately 6.2 million people of age 65 years and more are living with Alzheimer's-related dementia in the United States.

Development of New Technologies

Major players are investing in different therapies that will produce reliable results. Manufacturers are focusing on new therapies such as IgA, Plasmin, and Ceruloplasmin. This, in turn, is expected to create lucrative growth in the forecast period.

A rapid change in the healthcare sector, along with continuous technological innovation, shall accelerate demand for plasma fractionation in developing countries like North America. In 2019, there were around 195,263 people worldwide who had been diagnosed with hemophilia and 80,302 who had been diagnosed with von Willebrand disease.

Competitive landscape

Company Profiles: Detailed analysis of the major companies present in Global Plasma Fractionation Market.

  • Grifols S.A.

  • Octapharma AG

  • Intas Pharmaceuticals Ltd

  • LFB S.A.

  • Takeda Pharmaceutical Company Limited

  • CSL Limited

  • Biotest AG

  • Kedrion S.p.A

  • Bio Products Laboratory Ltd.'

  • Bharat Serums and Vaccines Limited

Report Scope:

Plasma Fractionation Market, By Product:

  • Albumin

  • Immunoglobulins

  • Coagulation Factors

  • Protease Inhibitors

  • Others

Plasma Fractionation Market, By Method:

  • Centrifugation

  • Depth Filtration

  • Chromatography

  • Others

Plasma Fractionation Market, By Application:

  • Neurology

  • Hematology

  • Oncology

  • Immunology

  • Others

Plasma Fractionation Market, By End User:

  • Hospitals & Clinics

  • Academic & Research Institutes

  • Others

Plasma Fractionation Market, By Region:

  • North America

  • United States

  • Canada

  • Mexico

  • Europe

  • France

  • Germany

  • United Kingdom

  • Italy

  • Spain

  • Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • South America

  • Brazil

  • Argentina

  • Colombia

  • Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Turkey

  • Egypt

For more information about this report visit https://www.researchandmarkets.com/r/srhpk0

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900